Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH; National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*. Busch MP, et al. Among authors: giachetti c. Transfusion. 2005 Dec;45(12):1853-63. doi: 10.1111/j.1537-2995.2005.00649.x. Transfusion. 2005. PMID: 16371038
Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
Busch MP, Tobler LH, Tegtmeier G, Polito A, Quan S, Hirschler NV, Dockter J, Giachetti C, Mimms L. Busch MP, et al. Among authors: giachetti c. Transfusion. 2000 Jan;40(1):10-4. doi: 10.1046/j.1537-2995.2000.40010010.x. Transfusion. 2000. PMID: 10644806 No abstract available.
Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.
Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP; Viral Activation Transfusion Study Group. Asmuth DM, et al. Among authors: giachetti c. Transfusion. 2003 Apr;43(4):451-8. doi: 10.1046/j.1537-2995.2003.00350.x. Transfusion. 2003. PMID: 12662277 Clinical Trial.
West Nile virus blood transfusion-related infection despite nucleic acid testing.
Macedo de Oliveira A, Beecham BD, Montgomery SP, Lanciotti RS, Linnen JM, Giachetti C, Pietrelli LA, Stramer SL, Safranek TJ. Macedo de Oliveira A, et al. Among authors: giachetti c. Transfusion. 2004 Dec;44(12):1695-9. doi: 10.1111/j.0041-1132.2004.04130.x. Transfusion. 2004. PMID: 15584982
Dynamics of viremia in early hepatitis C virus infection.
Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. Glynn SA, et al. Among authors: giachetti c. Transfusion. 2005 Jun;45(6):994-1002. doi: 10.1111/j.1537-2995.2005.04390.x. Transfusion. 2005. PMID: 15934999
Viral and host factors in early hepatitis C virus infection.
Mosley JW, Operskalski EA, Tobler LH, Andrews WW, Phelps B, Dockter J, Giachetti C, Busch MP. Mosley JW, et al. Among authors: giachetti c. Hepatology. 2005 Jul;42(1):86-92. doi: 10.1002/hep.20742. Hepatology. 2005. PMID: 15954090
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
Mosley JW, Operskalski EA, Tobler LH, Buskell ZJ, Andrews WW, Phelps B, Dockter J, Giachetti C, Seeff LB, Busch MP; Transfusion-transmitted Viruses Study and Retrovirus Epidemiology Donor Study Groups. Mosley JW, et al. Among authors: giachetti c. J Viral Hepat. 2008 Feb;15(2):120-8. doi: 10.1111/j.1365-2893.2007.00900.x. J Viral Hepat. 2008. PMID: 18184195
89 results